Technical Analysis for ABBV - AbbVie Inc.

Grade Last Price % Change Price Change
grade A 118.6 3.22% 3.70
ABBV closed up 3.22 percent on Friday, February 16, 2018, on 1.42 times normal volume.
20 Watchers
Track This Stock
Watchlist Portfolio

Trend Table & Recent Alerts
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Up Up Up
See historical ABBV trend table...

Date Alert Name Type % Chg
Feb 16 Wide Bands Range Expansion 0.00%
Feb 16 Overbought Stochastic Strength 0.00%
Feb 16 Up 3 Days in a Row Strength 0.00%
Feb 15 New Uptrend Bullish 3.22%
Feb 15 Spinning Top Other 3.22%
Feb 15 Wide Bands Range Expansion 3.22%
Feb 14 Calm After Storm Range Contraction 4.88%
Feb 14 Outside Day Range Expansion 4.88%
Feb 14 Wide Bands Range Expansion 4.88%
Feb 13 Calm After Storm Range Contraction 6.03%

Older signals for ABBV ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

AbbVie Inc., a research-based biopharmaceutical company, engages in the discovery, development, manufacture, and sale of pharmaceutical products worldwide. Its product portfolio includes a range of adult and pediatric pharmaceuticals, including HUMIRA, a biologic therapy administered as a subcutaneous injection to treat various autoimmune diseases; Synthroid used in the treatment of hypothyroidism; AndroGel, a daily testosterone replacement therapy; Creon, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Kaletra, a prescription anti-HIV-1 medicine used with other anti-HIV-1 medications to increase the chance of treatment response in people with HIV-1; and Lupron, a product for the palliative treatment of advanced prostate cancer. The company also offers TriCor and TRILIPIX, which are fibric acid derivatives that are indicated as adjuncts to diet to reduce total cholesterol, LDL cholesterol, and triglyceride levels; Niaspan, an extended release form of niacin that is indicated as an adjunct to diet to reduce total cholesterol, LDL cholesterol, and triglyceride levels, as well as to increase HDL cholesterol levels; Synagis, which protects at-risk infants from severe respiratory disease or respiratory syncytial virus; Sevoflurane, an anesthesia product for human use; Duodopa, a levodopa-carbidopa intestinal gel used to treat advanced Parkinson's disease; and Zemplar used for the prevention and treatment of secondary hyperparathyroidism. It sells its products to wholesalers, distributors, government agencies, health care facilities, specialty pharmacies, and independent retailers from its distribution centers and public warehouses. The company has collaboration with Alvine Pharmaceuticals, Inc. to develop a oral treatment for patients with celiac disease. AbbVie Inc. was incorporated in 2012 and is based in North Chicago, Illinois. As of January 01, 2013.AbbVie Inc. operates independently of Abbott Laboratories.
Is ABBV a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicator Value
52 Week High 125.86
52 Week Low 59.7387
Average Volume 6,212,156
200-Day Moving Average 85.1077
50-Day Moving Average 104.3382
20-Day Moving Average 112.7645
10-Day Moving Average 112.448
Average True Range 4.3012
ADX 24.13
+DI 30.12
-DI 24.68
Chandelier Exit (Long, 3 ATRs ) 112.9564
Chandelier Exit (Short, 3 ATRs ) 113.9036
Upper Bollinger Band 122.4574
Lower Bollinger Band 103.0716
Percent B (%b) 0.8
BandWidth 17.191403
MACD Line 2.9253
MACD Signal Line 3.0242
MACD Histogram -0.0989
Fundamentals Value
Market Cap 189.07 Billion
Num Shares 1.59 Billion
EPS 4.07
Price-to-Earnings (P/E) Ratio 29.14
Price-to-Sales 5.35
Price-to-Book 23.76
PEG Ratio 1.00
Dividend 2.56
Dividend Yield 2.16%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 124.60
Resistance 3 (R3) 124.13 121.67 123.60
Resistance 2 (R2) 121.67 120.14 121.90 123.27
Resistance 1 (R1) 120.13 119.19 120.90 120.60 122.93
Pivot Point 117.67 117.67 118.05 117.90 117.67
Support 1 (S1) 116.13 116.14 116.90 116.60 114.27
Support 2 (S2) 113.67 115.19 113.90 113.93
Support 3 (S3) 112.13 113.67 113.60
Support 4 (S4) 112.60